• court saves the day
    court saves the day
    0 Commentaires 0 Parts 22KB Vue
  • [OC] Workplace accident
    [OC] Workplace accident
    0 Commentaires 0 Parts 22KB Vue
  • Somewhere between teething and emotional breakup anthems.
    Somewhere between teething and emotional breakup anthems.
    0 Commentaires 0 Parts 22KB Vue
  • 【ガンダムSEED freedom】
    *マリュー ラミアス*

    Photo カサさん(@ambitious530 )

    #めぐcos #コスプレ #アコスタ羽田エアポートガーデン
    【ガンダムSEED freedom】 *マリュー ラミアス* Photo カサさん(@ambitious530 ) #めぐcos #コスプレ #アコスタ羽田エアポートガーデン
    0 Commentaires 0 Parts 22KB Vue
  • 𝐘𝐞̂𝐮 𝐞𝐦 đ𝐢 𝐞𝐦 𝐜𝐡𝐨 𝐜𝐡𝐨̛𝐦 𝐦𝐚́...
    𝐘𝐞̂𝐮 𝐞𝐦 đ𝐢 𝐞𝐦 𝐜𝐡𝐨 𝐜𝐡𝐨̛𝐦 𝐦𝐚́...
    0 Commentaires 0 Parts 22KB Vue
  • Ô tô con biến dạng hoàn toàn sau va chạm liên hoàn trên Quốc lộ 4D đoạn qua thị xã Sa Pa sáng 8/6, giao thông trên tuyến đèo huyết mạch này cũng ùn tắc kéo dài.

    Theo thông tin ban đầu, có một số người bị thương và được đưa đi cấp cứu.

    Theo: VTC News / Thủy Nguyễn
    Ô tô con biến dạng hoàn toàn sau va chạm liên hoàn trên Quốc lộ 4D đoạn qua thị xã Sa Pa sáng 8/6, giao thông trên tuyến đèo huyết mạch này cũng ùn tắc kéo dài. Theo thông tin ban đầu, có một số người bị thương và được đưa đi cấp cứu. Theo: VTC News / Thủy Nguyễn
    0 Commentaires 0 Parts 22KB Vue
  • Tuberculosis has plagued humanity for centuries, killing more people each year than nearly any other infectious disease. But scientists may have finally turned the tide. A new mRNA vaccine, dubbed mRNACV2, has demonstrated strong effectiveness in preclinical trials—triggering a powerful immune response in mice and dramatically reducing the bacterial load in their lungs. This represents a major leap beyond the current BCG vaccine, which offers limited protection and hasn't changed much since its introduction in 1921.

    What makes this breakthrough especially significant is the use of mRNA technology—the same approach that powered COVID-19 vaccines. This marks the first time mRNA has shown such promise against a bacterial infection, not just viruses. With human trials now on the horizon, the medical community is hopeful that this could lead to a durable, global solution for TB—a disease that still kills over 1 million people annually despite being preventable and treatable.

    #mRNAVaccine #TBCure #MedicalBreakthrough #InfectiousDiseases
    #PublicHealthRevolution
    Tuberculosis has plagued humanity for centuries, killing more people each year than nearly any other infectious disease. But scientists may have finally turned the tide. A new mRNA vaccine, dubbed mRNACV2, has demonstrated strong effectiveness in preclinical trials—triggering a powerful immune response in mice and dramatically reducing the bacterial load in their lungs. This represents a major leap beyond the current BCG vaccine, which offers limited protection and hasn't changed much since its introduction in 1921. What makes this breakthrough especially significant is the use of mRNA technology—the same approach that powered COVID-19 vaccines. This marks the first time mRNA has shown such promise against a bacterial infection, not just viruses. With human trials now on the horizon, the medical community is hopeful that this could lead to a durable, global solution for TB—a disease that still kills over 1 million people annually despite being preventable and treatable. #mRNAVaccine #TBCure #MedicalBreakthrough #InfectiousDiseases #PublicHealthRevolution
    0 Commentaires 0 Parts 22KB Vue
  • Who would've thought..
    Who would've thought..
    0 Commentaires 0 Parts 22KB Vue
  • BJ NomNom's personal experience
    BJ NomNom's personal experience
    0 Commentaires 0 Parts 22KB Vue